Busca avançada
Ano de início
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Detecting ovarian cancer using extracellular vesicles: progress and possibilities

Texto completo
Carollo, Emanuela [1] ; Paris, Bianca [1] ; Samuel, Priya [1] ; Pantazi, Paschalia [1] ; Bartelli, Thais Fernanda [1, 2] ; Dias-Neto, Emmanuel [2, 3] ; Brooks, Susan Ann [1] ; Pink, Ryan Charles [1] ; Carter, David Raul Francisco [1]
Número total de Autores: 9
Afiliação do(s) autor(es):
[1] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Oxford OX3 0BP - England
[2] AC Camargo Canc Ctr, Lab Med Genom, Sao Paulo, SP - Brazil
[3] Univ Sao Paulo, Inst Psiquiatria, Fac Med, Lab Neurosci Alzira Denise Hertzog Silva LIM 27, Sao Paulo, SP - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo de Revisão
Fonte: BIOCHEMICAL SOCIETY TRANSACTIONS; v. 47, n. 1, p. 295-304, FEB 28 2019.
Citações Web of Science: 2

Ovarian cancer (OC) is the deadliest gynecological malignancy. Most patients are diagnosed when they are already in the later stages of the disease. Earlier detection of OC dramatically improves the overall survival, but this is rarely achieved as there is a lack of clinically implemented biomarkers of early disease. Extracellular vesicles (EVs) are small cell-derived vesicles that have been extensively studied in recent years. They contribute to various aspects of cancer pathology, including tumor growth, angiogenesis and metastasis. EVs are released from all cell types and the macromolecular cargo they carry reflects the content of the cells from which they were derived. Cancer cells release EVs with altered cargo into biofluids, and so, they represent an excellent potential source of novel biomarkers for the disease. In this review, we describe the latest developments in EVs as potential biomarkers for earlier detection of OC. The field is still relatively young, but many studies have shown that EVs and the cargo they carry, including miRNAs and proteins, can be used to detect OC. They could also give insights into the stage of the disease and predict the likely therapeutic outcome. There remain many challenges to the use of EVs as biomarkers, but, through ongoing research and innovation in this exciting field, there is great potential for the development of diagnostic assays in the clinic that could improve patient outcome. (AU)

Processo FAPESP: 14/26897-0 - Epidemiologia e genômica de adenocarcinomas gástricos no Brasil
Beneficiário:Emmanuel Dias-Neto
Linha de fomento: Auxílio à Pesquisa - Temático
Processo FAPESP: 15/50257-3 - Extracellular vesicles and non-cellular RNA: roles in health and neglected tropical diseases | São Paulo - SP
Beneficiário:Emmanuel Dias-Neto
Linha de fomento: Auxílio à Pesquisa - Organização de Reunião Científica